Retinal Vein Occlusion With Drs. Sunil Srivastava and Rishi Singh
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with retinal vein occlusion.

In this podcast, expert clinicians will discuss current and future approaches for the management of patients with retinal vein occlusion.
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with neovascular age-related macular degeneration, dry age-related macular degeneration, and geographic atrophy.
In this podcast, expert clinicians will discuss current and future approaches for the management of patients with diabetic eye disease.
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degen...
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degen...
The angiopoietin/Tie2 pathway is an attractive therapeutic target for the management of retinal and choroidal vascular diseases, as it has been identified to play a role in vascular permeability and angiogenesis within the eye. Several therapies targeting this pathway have been investigated, and the FDA recently approved the first agent that inhibits both the angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A pathways for the treatment of neovascular age-related macular degen...
Steven Ferrucci, OD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 4 .
Rishi P. Singh, MD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 3 .
Steven Ferrucci, OD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 2 .
Rishi P. Singh, MD, provides an overview of the CE-certified ePublication, Retinal Disease Digest: Opportunities for Optometrists Volume 1, Issue 1 .
In this podcast, expert clinicians will discuss best practices for reducing ocular toxicities in myeloma patients through the multidisciplinary team.
In this podcast, expert clinicians will discuss strategies to mitigate and manage ocular toxicities related to multiple myeloma therapy.
In this podcast, expert clinicians will discuss the frequency and identification of ocular toxicities of patients on myeloma therapy.
In this podcast, expert clinicians will discuss the mechanisms behind ocular toxicities that have been associated with antibody drug conjugates used for cancer treatment.
This educational activity will review best practices regarding the use of gel stents in the treatment of glaucoma.
In this podcast, John Samples, MD, and Brian Francis, MD, discuss the current and evolving role of optical coherence tomography angiography in the management of glaucoma.
In this podcast, John Samples, MD, and Michael Giovigno, MD, review best practices for the use of cyclophotocoagulation in the management of glaucoma.
In this podcast, John R. Samples, MD, and Russell Swan, MD, discuss the relevance of cerebrospinal fluid pressure in the management of glaucoma.
This educational activity will review best practices in the management of patients with glaucoma.
Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions Volume 10, Issue 4
Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions Volume 10, Issue 3
Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions Volume 10, Issue 2
This educational podcast will review the use of combination therapy, new drug formulations, and procedures to improve outcomes for patients with ocular surface disease.
In this educational podcast, experts discuss emerging therapies for their ability to improve outcomes in patients with ocular surface disease. Faculty also review the safety and efficacy data to support new and emerging treatment options for OSD.
This educational podcast will review important considerations for the diagnosis and management of ocular surface disease (OSD) in special patient populations. Faculty will provide pearls for preventing and managing OSD in individuals at elevated risk, including those undergoing ocular surgery, those with glaucoma or diabetes, as well as individuals on medications known to disrupt the ocular surface.
Recap with Dr. Rishi Singh: An Overview of Intravitreal Interventions, Volume, 10, Issue 1
In this podcast, expert clinicians will discuss best practices regarding the use of Port Delivery System with ranibizumab.
In this podcast, expert clinicians will discuss achieving vascular stability through inhibition of Ang-2. To obtain CME credit, go here: https://tinyurl.com/y58538ef
In this podcast, expert clinicians will discuss emerging gene therapies for AMD and DME. To obtain CME credit, go here: https://tinyurl.com/yusxpn44
In this podcast, expert clinicians will discuss emerging delivery system devices in neovascular retinal disease. To obtain CME credit, please go here: https://tinyurl.com/thma9fwp